A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes - PubMed (original) (raw)
A viral epitope that mimics a self antigen can accelerate but not initiate autoimmune diabetes
Urs Christen et al. J Clin Invest. 2004 Nov.
Abstract
We document here that infection of prediabetic mice with a virus expressing an H-2Kb-restricted mimic ligand to a self epitope present on beta cells accelerates the development of autoimmune diabetes. Immunization with the mimic ligand expanded autoreactive T cell populations, which was followed by their trafficking to the islets, as visualized in situ by tetramer staining. In contrast, the mimic ligand did not generate sufficient autoreactive T cells in naive mice to initiate disease. Diabetes acceleration did not occur in H-2Kb-deficient mice or in mice tolerized to the mimic ligand. Thus, arenavirus-expressed mimics of self antigens accelerate a previously established autoimmune process. Sequential heterologous viral infections might therefore act in concert to precipitate clinical autoimmune disease, even if single exposure to a viral mimic does not always cause sufficient tissue destruction.
Figures
Figure 1
Molecular mimicry can accelerate but not easily initiate autoimmune diabetes. (A) Molecular mimicry is insufficient to prime naive autoreactive CD8 T cells and cause autoimmune diabetes. RIP-LCMV-NP mice were infected with 105 PFU LCMV-Arm (open circles), LCMV-Arm-Var (filled triangles), or PV alone (filled circles). (B) Primed autoreactive cells can become activated via molecular mimicry and accelerate disease. RIP-LCMV-NP mice were infected with either 105 PFU LCMV-Arm (open circles, filled circles) or 105 PFU PV (open triangles, filled triangles) on day 0 and, as indicated, received a secondary inoculation (2nd inf.) with PV (open triangles, filled circles) 28 days after the priming LCMV infection. As a comparison, the incidence data to RIP-LCMV-NP mice infected with LCMV alone are displayed (open circles). For both studies, blood glucose values were determined at weekly intervals. Mice with blood glucose levels above 300 mg/dl were considered diabetic. It is evident from these studies that secondary infection but not primary infection with PV can accelerate T1D development. Statistical analysis was done using the log rank test. Note that the diabetes onset curves for the groups LCMV alone versus LCMV-PV are significantly different (P = 0.0066).
Figure 2
CD8 T cell populations specific for the mimicking epitope PV-NP205 are significantly expanded after sequential infection with PV. (A and B) RIP-LCMV-NP and RIP-LCMV-NP × Kb(–) mice were infected with 105 PFU LCMV or PV. After 4 weeks, the mice received a secondary infection of either LCMV or PV. (A) Intracellular cytokine staining (ICCS) after stimulation with PV-NP205 is displayed for 1 representative mouse infected first with LCMV (LCMV alone) and then with PV (LCMV-PV) (mean frequencies are indicated in boxed areas). (B) The frequency of epitope-specific CD8 T cells in the blood was determined by ICCS for IFN-γ after stimulation with the indicated peptides (key) immediately before (upper panel) and 7 days after (lower panel) secondary infection. (C) Numbers of H-2Kb–restricted PV-NP205–specific lymphocytes after LCMV or PV infection, assessed by ICCS for IFN-γ. Splenocytes were harvested on day 35 from mice that received LCMV at day 0 (d0) and, for the PV group, PV at day 28 (d28). Means (± SEM) are displayed. (D) Lytic precursors after LCMV-NP396 versus PV-NP205 antigenic stimulation for 10 days. In addition to lytic activity, IFN-γ production was assessed in the supernatant of each well; wells with IFN-γ levels of more than 0.05 ng/ml by ELISA were counted as positive. IFN-γ production was on average 13 (± 3.5) ng/ml in LCMV-NP396–stimulated cultures and 7.1 (± 3.1) ng/ml in PV-NP205–stimulated cultures. This experiment was repeated three times and mean values (± SEM) are displayed. *P < 0.05.
Figure 3
Sequential infection with LCMV and PV results in accumulation of PV-NP205–specific CD8 T cells in the islets of Langerhans. (A) RIP-NP mice were infected with 105 PFU LCMV. After 4 weeks, one group of mice received a secondary infection of PV (105 PFU, i.p.). Left panels, pancreata were harvested at week 3 after secondary infection and 6-μm tissue sections were stained for cellular infiltration with a monoclonal antibody against CD8. Sections were counterstained with hematoxylin. Right panels, pancreata were harvested at day 5 after secondary infection and 6-μm tissue sections were cut and were stained for CD8 T cells with rhodamine X–conjugated anti-CD8 (red) and for PV-NP205–specific CD8 T cells with allophycocyanin-conjugated H-2Kb–PV-NP205 tetramers (green). Note that only after sequential infection with LCMV followed by PV are PV-NP205–specific CD8 T lymphocytes (yellow) found in the islets of Langerhans. Original magnification, ×20. (B) Expansion of PV-NP205–specific CD8 T cell populations in blood and pancreatic lymph nodes after secondary PV infection. Upper panels, flow cytometry of PV-NP205–specific CD8 T cells in the blood of LCMV-immune mice that did or did not receive secondary infection with PV, as detected by H-2Kb–PV-NP205 tetramers; mean frequencies are indicated in boxed areas. Lower panel, frequencies of PV-NP205–specific CD8 T cells were determined by flow cytometry using H-2Kb–PV-NP205 tetramer staining and by ICCS for IFN-γ expression after 5 hours of in vitro stimulation with PV-NP205 peptide.
Figure 4
H-2Kb–restricted, autoreactive, LCMV/PV-NP205–specific cross-reactive CD8 T cells mediate the acceleration of diabetes. (A and B) RIP-LCMV-NP or RIP-LCMV-NP × Kb(–) mice were infected with LCMV or PV. After 4 weeks, the mice received a secondary infection of PV. (A) Blood glucose of RIP-LCMV-NP, RIP-LCMV-NP × Kb(–), and RIP-LCMV-NP × Kb(+) littermates was measured in weekly intervals. The diabetes onset curves (blood glucose values > 300 mg/dl) for the groups [RIP-LCMV-NP × Kb(–) vs. RIP-LCMV-NP × Kb(+)] are significantly different (log rank test; P = 0.0167). (B) Pancreas sections from 3–4 mice per group at week 3 after secondary infection with PV were stained for cellular infiltration of CD8 T cells. Sections of 1 representative RIP-LCMV-NP × Kb(–) and RIP-LCMV-NP × Kb(+) mouse are shown. Original magnification, ×20. (C) Mice were tolerized to PV-NP205 by injection of 2 × 107 ECDI–PV-NP205–coupled autologous splenocytes (ECDI + NP205) or with 2 × 107 splenocytes treated with EDCI alone, 5 days before infection with 105 PFU LCMV. After 4 weeks, mice were infected with PV. Diabetes incidence (blood glucose values > 300 mg/dl) at week 4 after PV infection is displayed; numbers of mice analyzed per group are indicated in parentheses. (D and E) Groups of 3–4 mice were infected with LCMV. After 4 weeks, the mice received 100 μg of PV-NP205 peptide or an H-2Kb–restricted control peptide (OVA; SIINFEKL). In addition, mice received three injections of poly(I:C) (7.5 μg/g body mass) at the time of peptide injection and then at days 2 and 4 thereafter. Controls received PV-NP205 only or PV infection. (D) The frequency of blood LCMV/PV-NP205–specific cross-reactive CD8 T cells was assessed by flow cytometry using H-2Kb–PV-NP205 tetramers (day 7 after peptide injection). (E) Mean blood glucose values (± SEM) measured at week 2 after peptide and/or poly(I:C) injection is displayed.
Similar articles
- Comparing the relative role of perforin/granzyme versus Fas/Fas ligand cytotoxic pathways in CD8+ T cell-mediated insulin-dependent diabetes mellitus.
Kreuwel HT, Morgan DJ, Krahl T, Ko A, Sarvetnick N, Sherman LA. Kreuwel HT, et al. J Immunol. 1999 Oct 15;163(8):4335-41. J Immunol. 1999. PMID: 10510373 - Exposure to IL-15 and IL-21 enables autoreactive CD8 T cells to respond to weak antigens and cause disease in a mouse model of autoimmune diabetes.
Ramanathan S, Dubois S, Chen XL, Leblanc C, Ohashi PS, Ilangumaran S. Ramanathan S, et al. J Immunol. 2011 May 1;186(9):5131-41. doi: 10.4049/jimmunol.1001221. Epub 2011 Mar 23. J Immunol. 2011. PMID: 21430227 - Autoimmune disorders in diabetes.
Boitard C, Debray-Sachs M, Bach JF. Boitard C, et al. Adv Nephrol Necker Hosp. 1986;15:281-305. Adv Nephrol Necker Hosp. 1986. PMID: 3082114 Review.
Cited by
- Molecular Mechanisms Responsible for Diabetogenic Effects of COVID-19 Infection-Induction of Autoimmune Dysregulation and Metabolic Disturbances.
Grubišić B, Švitek L, Ormanac K, Sabo D, Mihaljević I, Bilić-Ćurčić I, Omanović Kolarić T. Grubišić B, et al. Int J Mol Sci. 2023 Jul 18;24(14):11576. doi: 10.3390/ijms241411576. Int J Mol Sci. 2023. PMID: 37511334 Free PMC article. Review. - Exploring the Implications of New-Onset Diabetes in COVID-19: A Narrative Review.
Pergolizzi J, LeQuang JAK, Breve F, Magnusson PM, Varrassi G. Pergolizzi J, et al. Cureus. 2023 Jan 3;15(1):e33319. doi: 10.7759/cureus.33319. eCollection 2023 Jan. Cureus. 2023. PMID: 36741600 Free PMC article. Review. - Adult-onset Still's disease after ChAdOx1 nCoV-19 vaccine: a possible association.
Albertino LF, Moulaz IR, Zogheib TF, Valentim MZC, Machado KLLL. Albertino LF, et al. Autops Case Rep. 2022 Nov 7;12:e2021403. doi: 10.4322/acr.2021.403. eCollection 2022. Autops Case Rep. 2022. PMID: 36426114 Free PMC article. - Machine-Learning-Assisted Analysis of TCR Profiling Data Unveils Cross-Reactivity between SARS-CoV-2 and a Wide Spectrum of Pathogens and Other Diseases.
Georgakilas GK, Galanopoulos AP, Tsinaris Z, Kyritsi M, Mouchtouri VA, Speletas M, Hadjichristodoulou C. Georgakilas GK, et al. Biology (Basel). 2022 Oct 19;11(10):1531. doi: 10.3390/biology11101531. Biology (Basel). 2022. PMID: 36290433 Free PMC article. - Infections in the first year of life and development of beta cell autoimmunity and clinical type 1 diabetes in high-risk individuals: the TRIGR cohort.
Kordonouri O, Cuthbertson D, Belteky M, Aschemeier-Fuchs B, White NH, Cummings E, Knip M, Ludvigsson J. Kordonouri O, et al. Diabetologia. 2022 Dec;65(12):2098-2107. doi: 10.1007/s00125-022-05786-3. Epub 2022 Sep 9. Diabetologia. 2022. PMID: 36083343 Free PMC article. Clinical Trial.
References
- Menser MA, Forrest JM, Bransby RD. Rubella infection and diabetes mellitus. Lancet. 1978;1:57–60. - PubMed
- Notkins, A.L., and Yoon, J.-W. 1984. Virus-induced diabetes mellitus. In Concepts in Viral Pathogenesis. A.L. Notkins and M.B.A. Oldstone, editors. Springer-Verlag. New York, New York, USA. 241–247.
- Yoon J-W. The role of viruses and environmental factors in the induction of diabetes. Curr. Top. Microbiol. Immunol. 1990;164:95–123. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- NS041219/NS/NINDS NIH HHS/United States
- U19 AI051973/AI/NIAID NIH HHS/United States
- AI51973/AI/NIAID NIH HHS/United States
- DK58541/DK/NIDDK NIH HHS/United States
- AI09484/AI/NIAID NIH HHS/United States
- R01 DK058541/DK/NIDDK NIH HHS/United States
- DK51091/DK/NIDDK NIH HHS/United States
- R29 DK051091/DK/NIDDK NIH HHS/United States
- R01 DK051091/DK/NIDDK NIH HHS/United States
- R01 AI044451/AI/NIAID NIH HHS/United States
- R01 AI009484/AI/NIAID NIH HHS/United States
- AI44451/AI/NIAID NIH HHS/United States
- T32 NS041219/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases